By combining your genetic predisposition data with baseline biomarkers (insulin, glucose, inflammatory markers, lipids) and clinical history, you and your provider can make a more informed decision about whether maintenance GLP-1 therapy, alternative compounds, or intensive behavioral interventions are most likely to support sustainable weight maintenance for your specific situation
Exploring the impact of high-fat diet on gut microbiota composition in healthy individuals: a comprehensive analysis
Scientists are increasingly exploring whether medications already used for Type 2 diabetes mellitus and obesity could help reduce cravings and substance dependence
Additionally, SCFAs are vital in determining the differentiation, quantity, and secretory capabilities of enteroendocrine cells, which affects both the baseline and stimulus-induced neuroendocrine responses [119,120]